Dmannose Pills Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

NOW is the best-performing dmannose pills brand in July 2026, moving 14,000 units across 3 ASINs for 29.2% of Top 10 volume. Uqora follows with 11,000 units (22.9%), ahead of AZO on 10,000 units (20.8%).

With 7 brands splitting the Top 10 and 72.9% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $21.11 to $27.49, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B01L2TFP1Q booked 2K units at $29.95, with ▲ 0.0% MoM change. On the growth side, B0GWMMXDB6 leads positive momentum with ▲ 300.0% MoM growth on 200 units, with B00P1SOMUU close behind at ▲ 100.0% MoM on 200 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.